Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
January 30, 2024 16:05 ET
|
Biostem Technologies
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
January 11, 2024 08:30 ET
|
Biostem Technologies
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer role
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
December 19, 2023 08:30 ET
|
Biostem Technologies
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions
December 14, 2023 08:30 ET
|
Biostem Technologies
The Center for Medicare Services (CMS) has established national pricing for AmnioWrap2(TM) in all Medicare Administrative Contractors (MAC) regions
BioStem Technologies Commends OIG's Recommendation for CMS to Address ASP Reporting Requirements for Skin Substitute Products
March 23, 2023 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., March 23, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies (“BioStem” or the “Company”) (OTCQB: BSEM), a leading provider of innovative regenerative medicine solutions, is...
BioStem Technologies® CEO to Appear on the Benzinga All Access Show on June 17,2022
June 17, 2022 09:25 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA, June 17, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies® (OTC: BSEM), a leading, innovator focused on harnessing the natural properties of perinatal tissue in the development,...
BioStem Technologies Reports March 31, 2022 Record Quarterly Financial Results
May 16, 2022 12:25 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., May 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies Announces Veterans Day Fundraiser to Support America's VetDogs®
November 01, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., Nov. 01, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. and its subsidiary Blue Tech Industries, Inc. (d/b/a BioStem Life Sciences), a Certified VOSB (Veteran-Owned Small...
BioStem Technologies Reports Record Breaking Second Quarter Sales
August 25, 2021 11:15 ET
|
BioStem Technologies, Inc.
Company on Pace to Exceed 2020 Revenues in 2021 Pompano Beach, Fl., Aug. 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life...
BioStem Technologies, Inc., Announces the Engagement of Biologics Consulting To Support FDA Strategies and Submissions.
July 27, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., July 27, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...